An observational study in Postoperative Complication, Respiratory Complications and Cardiac Complications, sponsored by Azienda Ospedaliero-Universitaria di Parma. Recruiting at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-28.
Sponsored by Azienda Ospedaliero-Universitaria di Parma · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 59 studies in Postoperative Complications with a site in Italy — 16 open to participants now, 18 under way, 1 of them phase 3. Postoperative Complications · Italy.
Among the 59 studies in Postoperative Complications with a site in Italy, this one is the 18th largest by planned enrollment of the 23 observational ones that give a count, is one of 8 that started in 2026, is one of 23 observational ones, reaches primary completion later than 10 of the 17 other live ones, and was the 55th registered.
1,343 studies on the registry are indexed under Postoperative Complications; 314 are open to participants now.
Browse Postoperative Complications studies →16 of the 59 studies in Postoperative Complications with a site in Italy are open now. Recruiting first, the newest first:
IRCCS San Raffaele · Sites in Italy
Ages 18+
Societa Italiana Anestesia Analgesia Rianimazione e Terapia Intensiva · Sites in Italy
Ages 18+
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria · Sites in Italy
Ages 18+
Zealand Pharma · Sites in Italy, United States, Austria and 11 more countries
Ages 18–90
Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital · Sites in Italy, Turkey
Ages 18+
A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →
Of the 200 Postoperative Complications studies recruiting now, 126 (63%) set no upper age limit and 31 (16%) stop at 75 or younger; 24 take children under 18; 25 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
59 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 3 · Phase 3 3 · Phase 4 1
First in 1998; this study’s year is marked. 8 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 150 is below the median of 251 across 541 observational studies indexed under Postoperative Complications.
Median enrollment 150 across the 35 interventional studies, 500 across the 23 observational. Of the 31 that completed or were terminated, 2 (6%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 59 have an industry lead sponsor. The 10 most frequent:
Azienda Ospedaliero-Universitaria di Parma is the lead sponsor of 44 studies on the registry; 13 are open to participants now.
Azienda Ospedaliero-Universitaria di Parma has 3 studies filed under Postoperative Complications — fewer than ten, so there is no comparison to draw.
8 of the studies in Postoperative Complications with a site in Italy that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06069297IRCCS San RaffaelePrehabilitation in Pancreatic Surgery | 2026-12-16 |
| NCT07313839Azienda Ospedaliero-Universitaria di ParmaComparison of Self-Locking Versus Traditional Sutures in Double-Layer Laparoscopic Vaginal Vault Closure After Hysterectomy (BI-SURE Trial) | 2027-01 |
| NCT07949526IRCCS San RaffaeleCompressive Dressing and Pharyngocutaneous Fistula After Primary Total Laryngectomy | 2027-01-05 |
| NCT07729891Azienda Ospedaliero-Universitaria di ParmaReal-time Evaluation and Continuous Observation of Vital Signs for Enhanced Recovery: a Study for the Early Identification of Complications in the Surgical Ward Following Surgery in Patients Not Eligible for Intensive Care Admission. | 2027-02 |
| NCT06904872Napo Therapeutics, S.p.A.Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC) | 2027-03 |
Add all 8 to your calendar (.ics) → With an account.
Among the 59 studies in Postoperative Complications with a site in Italy, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to evaluate whether continuous vital sign monitoring with wearable devices can help detect postoperative complications in surgical ward earlier than standard hospital monitoring. In particular, the goal of this observational study is to evaluate if the wireless wearable devices Portrait Mobile (GE Healthcare) can detect early signs of complications after major urologic surgery in adults who are not eligible for intensive care unit admission. The main questions it aims to answer are:
The RECOVER study evaluates the use of continuous wearable monitoring in surgical ward for the early detection of postoperative complications in patients recovering after major surgery. The study begins with the evaluation of urologic surgery. It focuses on whether continuous measurement of vital signs in the surgical ward can identify clinical deterioration and postoperative complications earlier than routine postoperative surveillance alone: postoperative complications are often preceded by changes in vital signs and may develop during the first days after surgery, when patients are usually monitored intermittently in the ward. Continuous wireless monitoring is intended to provide earlier recognition of respiratory and hemodynamic deterioration while patients recover outside the operating room and outside intensive care.
The main objective is to assess whether continuous monitoring of vital signs can detect early signs of medical or surgical postoperative complications after moderate-to-high complexity urologic surgery performed under general anesthesia. The protocol is particularly focused on identifying episodes of desaturation, tachypnea, hemodynamic instability, and persistent deviation of vital signs from patient's baseline values during the postoperative period.
Patient enrollment takes place in the Urology ward before the scheduled operation. During the preoperative anesthesiology evaluation, the anesthesiologist provides study information and asks the patient to participate by signing informed consent and personal data processing forms. This enrollment process is maintained in both patient pathways described in the protocol.
For patients managed with continuous monitoring, the wearable system is applied on the evening before surgery so that baseline vital sign values can be collected under resting conditions. Monitoring is interrupted before transfer to the operating room and restarted after the patient returns from surgery to the ward. The patient then wears the system for at least 72 hours after surgery, and the device does not replace standard postoperative monitoring.
The wearable platform used in the protocol is the Portrait Mobile® system by GE HealthCare. It continuously records respiratory rate, oxygen saturation, and heart rate, while blood pressure and EKG continues to be measured intermittently according to usual ward practice in order to maintain the non-intensive care settings and the actual patient-nurse ratio. Data are transmitted through the hospital Wi-Fi network to a dedicated monitoring infrastructure, where alarms can be visualized on the ward monitoring station.
Alarm thresholds are predefined by the investigator using values derived from the National Early Warning System Score. These thresholds include respiratory rate below 11 or above 21 breaths per minute, oxygen saturation below 95%, and heart rate below 50 or above 91 beats per minute. In addition to threshold-based events, the protocol evaluates persistent deviation from baseline, defined as a change greater than 20% for at least 24 hours, in order to capture clinically meaningful trends rather than isolated abnormal values.
When an alarm is generated, ward nursing staff are asked to determine whether the alert is appropriate or represents a false positive. They also record whether the patient is at rest or moving at the time of the alert, allowing the investigators to assess device performance under real clinical conditions. Subsequent clinical actions, including review by the ward physician, on-call physician activation, or request for anesthesiology consultation, are reconstructed from nursing handover and the clinical chart.
For patients managed with usual postoperative surveillance alone, enrollment still occurs during the preoperative anesthesiology assessment and clinical data are collected after informed consent is obtained. These patients receive standard ward monitoring without wearable continuous monitoring, and their postoperative course is documented for comparison of clinical events and outcomes.
The primary endpoints are the number of desaturation events, tachypnea events, and hemodynamic instability events. Secondary endpoints include false positive rate, number of physician alerts, number of requests for intensive care consultation, unplanned intensive care admission directly from the operating area, transfer to intensive care during postoperative ward stay, postoperative complications, re-surgery, correlation between parameter trends and outcomes, hospital length of stay, barriers to rehabilitation, patient satisfaction, and integration of the system with the hospital IT infrastructure.
All complications will be recorded in the case report form and graded according to the Clavien-Dindo classification. Collected data include baseline patient characteristics, average preoperative vital sign values, diagnosis, type of surgery, intraoperative data, continuous monitoring data, postoperative clinical course, pain, functional recovery, total hospital stay, ICU stay, and patient satisfaction with the monitoring system.
The system is not expected to expose patients to additional risk and does not interfere with the usual diagnostic and therapeutic pathway. Wireless wearable monitoring should not negatively affect mobilization, rehabilitation, or functional recovery, which is relevant because preservation of postoperative recovery is one of the practical concerns addressed by the study.
Adult patients undergoing to major urological surgery performed under general anesthesia and without a planned intensive care unit admission.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
100 patients receiving standard intermittent nurse vital sign check
50 patients receiving wearable device continuous vital sign monitoring with Portrait Mobile (GE Healthcare). Parameters monitored: Heart Rate, SpO2, Respiratory Rate.
Device: Continuous vital sign monitoring with Portrait Mobile in surgical ward
The wearable system is applied on the evening before surgery so that baseline vital sign values can be collected under resting conditions. Monitoring is interrupted before transfer to the operating room and restarted after the patient returns from surgery to the ward. The patient then wears the system for at least 72 hours after surgery. Respiratory rate, oxygen saturation, and heart rate are continuously collected, while blood pressure and EKG continues to be measured intermittently according to usual ward practice in order to maintain the non-intensive care settings and the actual patient-nurse ratio. Alarm thresholds are predefined by the investigator using values derived from NEWS and alarms calibrated over baseline parameters.
Number of event of desaturation
An 'event' among the primary outcomes will be those used by the National Early Warning System Score (NEWS: Respiratory rate \<11 and \>21 breaths/min; SpO₂ \<95%; Heart rate \<50 bpm and \>91 bpm)
Time frame: 72 hours after the surgery
Number of event of tachypnoea or bradypnoea
An 'event' among the primary outcomes will be those used by the National Early Warning System Score (NEWS: Respiratory rate \<11 and \>21 breaths/min; SpO₂ \<95%; Heart rate \<50 bpm and \>91 bpm)
Time frame: 72 hours after the surgery
Number of event of haemodinamic instability
An 'event' among the primary outcomes will be those used by the National Early Warning System Score (NEWS: Respiratory rate \<11 and \>21 breaths/min; SpO₂ \<95%; Heart rate \<50 bpm and \>91 bpm)
Time frame: 72 hours after the surgery
False-positive rate
Number of alarms triggered without a real Event
Time frame: 72 hours after the surgery
Number of on-call doctor call-outs
Nurse activation of the medical staff of the surgery ward
Time frame: 72 hours after the surgery
Number of requests for Anesthesia consultation
Activation of Hospital medical emergency team
Time frame: 72 hours after surgery
Unscheduled direct admission to the Intensive Care Unit from the operating theatre and unplanned transfer to the Intensive Care Unit during the post-operative period (from the surgical ward)
After Anesthesiological evaluation and activation of Hospital medical emergency team
Time frame: 72 hours after surgery
Occurrence of post-surgical complications (any type) or reoperation
Any type of complication and their severity (Clavien Dindo score) that occur during the intervention period
Time frame: 72 hours after surgery or patients discharge
Correlation between parameters trend, including persistent deviation from pre-operative values, and patient outcome or length of hospital stay.
To investigate the incidence of complication and/or prolonged LOS if the patient experience a progressive postoperative deviation from baseline vital parameters.
Time frame: Untill patient discharge from hospital
Barriers to patient rehabilitation and patients satisfaction
Investigate whether the wearable device hinders patient rehabilitation, expressed as the percentage of patients reporting a reduced capacity for postoperative early mobilization or rehabilitation, and patients global satisfaction through a questionnaire.
Time frame: 72 hours after surgery or discharge
Plan to share: Yes — Raw IPD that underlie results
Supporting information: Study protocol, Statistical analysis plan, Clinical study report
Time frame: At the end of enrollment and data collection
Access criteria: Upon request to the Principal Investigator
Started Feb 2026 (actual). Primary completion is estimated for Feb 2027, 12 months after the start.
Of 276 non-industry observational studies under Postoperative Complications, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 39. This study's planned 12 months is below that.
Counting every sponsor, half of 281 studies reached it within 22 months; a quarter within 10 and three quarters within 39.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Azienda Ospedaliero-Universitaria di Parma